United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42291-154_3ab20dcb-627a-53c4-e063-6394a90a20cb
- Product NDC
- 42291-154
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- AvKARE
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200403
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE (42291-154-10) · 42291-154-10
- 120 TABLET, FILM COATED in 1 BOTTLE (42291-154-12) · 42291-154-12
- 180 TABLET, FILM COATED in 1 BOTTLE (42291-154-18) · 42291-154-18
- 270 TABLET, FILM COATED in 1 BOTTLE (42291-154-27) · 42291-154-27
- 30 TABLET, FILM COATED in 1 BOTTLE (42291-154-30) · 42291-154-30
- 45 TABLET, FILM COATED in 1 BOTTLE (42291-154-45) · 42291-154-45
- 60 TABLET, FILM COATED in 1 BOTTLE (42291-154-60) · 42291-154-60
- 90 TABLET, FILM COATED in 1 BOTTLE (42291-154-90) · 42291-154-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →